- Home
- RGNX vs SEAT Comparison
RGNX vs SEAT Comparison
Compare RGNX & SEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- SEAT
- Stock Information
- Founded
- RGNX 2008
- SEAT 2001
- Country
- RGNX United States
- SEAT United States
- Employees
- RGNX N/A
- SEAT N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- SEAT Industrial Machinery/Components
- Sector
- RGNX Health Care
- SEAT Industrials
- Exchange
- RGNX Nasdaq
- SEAT Nasdaq
- Market Cap
- RGNX 387.0M
- SEAT 366.2M
- IPO Year
- RGNX 2015
- SEAT N/A
- Fundamental
- Price
- RGNX $8.85
- SEAT $1.56
- Analyst Decision
- RGNX Strong Buy
- SEAT Buy
- Analyst Count
- RGNX 8
- SEAT 11
- Target Price
- RGNX $31.75
- SEAT $4.49
- AVG Volume (30 Days)
- RGNX 1.3M
- SEAT 2.5M
- Earning Date
- RGNX 05-12-2025
- SEAT 05-06-2025
- Dividend Yield
- RGNX N/A
- SEAT N/A
- EPS Growth
- RGNX N/A
- SEAT N/A
- EPS
- RGNX N/A
- SEAT N/A
- Revenue
- RGNX $156,718,000.00
- SEAT $748,757,000.00
- Revenue This Year
- RGNX $313.52
- SEAT N/A
- Revenue Next Year
- RGNX N/A
- SEAT $4.84
- P/E Ratio
- RGNX N/A
- SEAT N/A
- Revenue Growth
- RGNX 80.70
- SEAT 0.82
- 52 Week Low
- RGNX $5.04
- SEAT $1.54
- 52 Week High
- RGNX $15.36
- SEAT $5.90
- Technical
- Relative Strength Index (RSI)
- RGNX 51.64
- SEAT 31.24
- Support Level
- RGNX $7.68
- SEAT $1.78
- Resistance Level
- RGNX $9.29
- SEAT $1.90
- Average True Range (ATR)
- RGNX 0.85
- SEAT 0.13
- MACD
- RGNX -0.08
- SEAT -0.01
- Stochastic Oscillator
- RGNX 43.42
- SEAT 2.80
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About SEAT Vivid Seats Inc.
Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale. Marketplace segment, act as an intermediary between ticket buyers, sellers, and partners through which company earn revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. Resale segment provides internal research and development support for Skybox and supplements ongoing efforts to deliver software and tools. Majority of revenue is from Marketplace segment.